10 Results for "

Tolvaptan

" in MedChemExpress (MCE) Product Catalog:
Products (10)

10 Results for "Tolvaptan" in MCE Product Catalog:

20
20 Cited Publications
Cat. No.: HY-17000
CAS No.: 150683-30-0
Synonyms: OPC-41061
Tolvaptan is a selective, competitive and orally active vasopressin receptor 2 (V2R) antagonist with an IC50 of 1.28 μM for the inhibition of arginine vasopressin (AVP)-induced platelet aggregation. Tolvaptan induces cell apoposis and affects cell cycle. Tolvaptan can be used for the research of hyponatremia .
loading...
    loading...
Cat. No.: HY-42476
CAS No.: 137977-97-0
Synonyms: 1-(4-Amino-2-methylbenzoyl)-7-chloro-1,2,3,4-tetrahydro-5H-1-benzazepin-5-one
Target:  

Drug Intermediate

Research Areas:  

Others

Tolvaptan Impurity (1-(4-Amino-2-methylbenzoyl)-7-chloro-1,2,3,4-tetrahydro-5H-1-benzazepin-5-one) is a drug intermediate for synthesis of various active compounds.
loading...
    loading...
Cat. No.: HY-157220
CAS No.: 942619-79-6
Purity:  99.85%
Target:  

Vasopressin Receptor

Research Areas:  

Cardiovascular Disease

Tolvaptan phosphate ester sodium, a prodrug of Tolvaptan (HY-17000), can be used in the study of cardiac edema. Tolvaptan is a selective, competitive and orally active vasopressin receptor 2 (V2R) antagonist with an IC50 of 1.28 μM for the inhibition of arginine vasopressin (AVP)-induced platelet aggregation .
loading...
    loading...
Cat. No.: HY-17000R
CAS No.: 150683-30-0
Synonyms: OPC-41061 (Standard)
Tolvaptan (Standard) is the analytical standard of Tolvaptan. This product is intended for research and analytical applications. Tolvaptan is a selective, competitive and orally active vasopressin receptor 2 (V2R) antagonist with an IC50 of 1.28 μM for the inhibition of arginine vasopressin (AVP)-induced platelet aggregation. Tolvaptan induces cell apoposis and affects cell cycle. Tolvaptan can be used for the research of hyponatremia .
loading...
    loading...
Cat. No.: HY-17000S
CAS No.: 1246818-18-7
Tolvaptan-d7 is the deuterium labeled Tolvaptan. Tolvaptan is a selective, competitive arginine vasopressin receptor 2 antagonist with an IC50 of 1.28μM for the inhibition of AVP-induced platelet aggregation .
loading...
    loading...
Cat. No.: HY-17000A
CAS No.: 331947-66-1
Synonyms: (R)-(+)-OPC-41061
Target:  

Vasopressin Receptor

Research Areas:  

Others

(R)-(+)-Tolvaptan ((R)-(+)-OPC-41061) is the (R)-(+) enantiomer of Tolvaptan (HY-17000). Tolvaptan (OPC-41061) is a selective, competitive and orally active vasopressin receptor 2 (V2R) antagonist .
loading...
    loading...
Cat. No.: HY-131679S
CAS No.: 1296212-29-7
5-Dehydro Tolvaptan-d7 is the deuterium labeled 5-Dehydro Tolvaptan .
loading...
    loading...
Cat. No.: HY-W702907
CAS No.: 1346599-56-1
Target:  

P-glycoprotein

Research Areas:  

Metabolic Disease

DM-4103 is a major metabolite of Tolvaptan (HY-17000) that is metabolized primarily by the CYP3A4 enzyme in the liver. DM-4103 inhibits the ability of human liver transporters NTCP, BSEP, MRP2, MRP3, MRP4 (IC50 values are 16.3, 4.15, 51.0, 44.6, 4.26 μM, respectively) and bile acid transport in SCHH cells. DM-4103 can be used in the study of autosomal dominant polycystic kidney disease (ADPKD) .
loading...
    loading...
Cat. No.: HY-165423
CAS No.: 926035-36-1
DM-4111, one of the major monohydroxyl metabolites of Tolvaptan (HY-17000), is a potent vasopressin V2 receptor inhibitor. DM-4111 inhibits water reabsorption in the renal tubules, thereby promoting the excretion of electrolyte-free water. DM-4111 is promising for research of cardiovascular diseases .
loading...
    loading...
Cat. No.: HY-W702908
CAS No.: 1346599-75-4
Target:  

P-glycoprotein

Research Areas:  

Metabolic Disease

DM-4107 is a major metabolite of Tolvaptan (HY-17000) that is metabolized primarily by the CYP3A4 enzyme in the liver. DM-4107 inhibits the ability of human liver transporters NTCP, BSEP, MRP3, MRP4 (IC50 values are 95.6, 119, 61.2, 37.9 μM, respectively) and bile acid transport in SCHH cells. DM-4107 can be used in the study of autosomal dominant polycystic kidney disease (ADPKD) .
loading...
    loading...